DR HARDIK ASSISTANT PROFESSOR DEPT OF SURGERY GMC SURAT

Slides:



Advertisements
Similar presentations
Approach to a patient with jaundice
Advertisements

 Treatment of malignant obstruction  Adjunct to surgery  Treatment of CBD calculi  Treatment of benign strictures  Diagnostic?  Failed ERCP.
Jaundice Dr. Firas Obeidat, MD.
Supervised by Dr. Jamal Hamdi
Liver Function Tests (LFTs)
JAUNDICE Index Case Term 2.
Hepatobiliary Anatomy and Pathology
Tumors of the bile ducts
J AUNDICE Mohammed Al- Rajeh & Shreef Al- Qahtani.
Biliary Tumors Cholangiocarcinoma and Cancer of the Gall Bladder
Gallstone Disease.
THE GALLBLADDER AND THE BILIARY TREE BY MICHAEL BRILLANTES, MD, FPCS, FPSGS.
Hepatic And Post-hepatic Jaundice Sonal Pruthi Roll Number - 82.
Biliary System Heartland Society of Gastroenterology Nurses and Associates Mary Ganley RN CGRN BSHA.
DR. WILLIAM OLALIA MATIAS  MAULION  MEDENILLA  MEDINA.
Gallbladder & bile duct Carcinoma Dr. m. h.khosravi.
Diagnostic studies Blood Tests Imaging Modalities Reference: Schwartz’s Principles of Surgery 8 th Edition.
Adult Medical- Surgical Nursing Gastro-intestinal Module: Liver Cirrhosis.
Behzad Nakhaei, M.D., FICS Fellowship in HepatoBiliary Surgery Mc Gill University RUQ & Upper Abdomen Inflammation & Infection GallBladder & Biliary System.
Histopathology and cytology (MLHC-201) Faculty of allied medical sciences.
Primary Sclerosing Cholangitis
Clinical Approach to Neonatal Jaundice
CHOLANGIOCARCINOMA (KLATSKIN TUMOUR). TR, 84 YRS FEMALE, BG- OSTEOARTHRITIS Admitted with painless obstructive jaundice Admitted with painless obstructive.
PANCREATIC CANCER.
Aswad Habeeb Hameed Al-Obeidy FICMS GE & Hep
Pathophysiology Complications Diagnosis Treatment
Jennifer Borja Raiza Bondoc
OBSTRUCTIVE JAUNDICE DR.JAMIL SAWAKED.
Introduction: AP is a common diagnosis. > 240,000/year reported annually in US. Gallstone, the most common cause, 50%. The outcome depends on the severity.
ERCP and Sphincterotomy Raika Jamali M.D. Gastroenterologist and hepatologist Tehran University of Medical Sciences.
Pancreatic cancer WU JIAN Department of hepatobiliary Surgery First Affiliated Hospital Zhejiang University School of Medicine.
Blood Studies Liver function test (LFT) Group of biochemical tests Group of biochemical tests Uses of liver function test (LFTs) Differential diagnosis.
Faisal Al-Saif MBBS, FRCSC, ABS. - Acute Pancreatitis - Chronic Pancreatitis - Pancreatic Tumors - Pancreas Transplant.
GROUP C Salazar, Riccel Salcedo, Von Saldana, Emmanuel Sales, Maria Stephanie Salonga, Cryscel September 21, 2009.
Clinical round By Dr. Ehab M. Oraby
FINAL DIAGNOSIS. PatientCholedocholithiasis Signs & symptoms -Painless jaundice -Tea-colored urine - (-) acholic stools - (-) fever - (-) weight loss.
KADA DA, A KADA NE ERCP Prof.dr.sc.Žarko Babić KB Dubrava, Zagreb Klinika za unutarnje bolesti Zavod za gastroenterologiju Odjel za gastroenterologiju.
Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4.
Pancreatic Cancer: The Silent Killer By Suzanne Sica Class 2008.
CHOLEDOCHAL CYST – A CASE REPORT PRESENTING AUTHOR – DR.K.PRASANNA POST GRADUATE STUDENT, RAJAH MUTHIAH MEDICAL COLLEGE & HOSPITAL (RMMCH), ANNAMALAI UNIVERSITY,
Laboratory Work-Up Reference Direct Bilirubin Indirect Bilirubin Total Bilirubin SGPT/ALT SGOT/AST
Holdorf. OUTLINE PART 2 Pit OUTLINE PART 2  Laboratory values  Gallbladder carcinoma  Adenomyomatosis  Biliary obstruction  Common duct measurement.
Biliary Imaging Ian Scharrer, MIV. Clinical Scenario A 46 year old woman presents to the clinic complaining of epigastric pain that she experiences after.
Lab # 2 Liver Function Tests (LFTs) ALT&AST T.A. Bahiya M. Osrah.
Tumors of the Biliary System. Anatomy Gallbladder Cancer Usually seen in the elderly Diagnosis at advanced stage, unless discovered incidentally during.
Obstructive Jaundice Surgical and Non Surgical Treatment
Digestive system Diagnostic imaging department of xuzhou medical college of xuzhou medical college.
1-urin and stool findings: hemolyticobstructivehepatocellular Urine bilinogenincreasedabsentMay increase or decrease Faeces stercobilinincreaseddecreasedDecreased.
Liver Function Tests (LFTs)
Imaging in Surgical Obstructive Jaundice
Liver Function Tests (LFTs)
CBD Stones, Stricture Carcinoma Gall Bladder Cholangiocarcinoma
Obstructive jaundice Etiology :
Treatment of Pancreatitis MLTTP (case study)
Chronic pancreatitis It is a chronic inflammatory disease due to repeated bouts of pancreatitis in which there is irreversible destruction of pancreatic.
RADICAL WHIPPLE`S PANCREATODUODENECTOMY FOR CHRONIC PANCREATITIS
Role of ERCP in patients with PSC
BY DR WAQAR MBBS, MRCP ASSISTANT PROFESSOR INTERNAL MEDICINE JAUNDICE BY DR WAQAR MBBS, MRCP ASSISTANT PROFESSOR INTERNAL MEDICINE.
JAUNDICE.
Assessing Biliary Pathology
Pancreatic Cancer What you need to know to be able to educate your patients and their families.
Abdominal Sonography Part 1 The Biliary Tract Part II
Cholangiocarcinoma.
Biliary imaging: a review1
Additional Suffixes & Digestive System Terminology
Review of Anatomy and Physiology
Cystic Neoplasm of the Pancreas Clinical Review of 60 Cases and Treatment Strategy D.K.Kim, S.I.Noh, J.S.Heo, J.H.Noh, T.S.Sohn, S.J.Kim, S.H.Choi, J.W.Joh,
Primary Sclerosing Cholangitis Interpreting your tests
Presentation transcript:

DR HARDIK ASSISTANT PROFESSOR DEPT OF SURGERY GMC SURAT Obstructive Jaundice DR HARDIK ASSISTANT PROFESSOR DEPT OF SURGERY GMC SURAT

Jaundice It’s a French word meaning Yellow. Jaundice is a term used for yellow pigmentation of sclera skin or mucus membrane due to deposition of Bilirubin. Normal Bilirubin is 0.2-1.0mg/dL. Jaundice clinically detected in sclera when S.Billirubin is >2.5mg/dl. Jaundice is clinically detected in Skin/Mucus Membrane when S. Billirubin is >6.0mg/dl.

Billirubin Metabolism Bile contains Bile salt. Lecithin Cholesterol Bile Pigment Biles Salt are Primary(Cholate & Chenodeoxycholate) Secondary(Deoxycholate & Lithocholate)

Entero hepatic Circulation Bile salt in Bile Jejunum & Ileum it help in fat Digestion Reabsorption in terminal Ileum Portal Vein Blood Liver Entire Bile Salt Pool of 2.5-4.0gm circulates twice through the enterohepatic circulation during each Meal.

Bilirubin Metabolism

Difference Between the types of Jaundice HEMOLYTIC HEPATIC OBSTRUCTIVE AGE YOUNG YOUNG/MIDDLE AGE OLDER AGE GROUP ABDOMINAL PAIN NO +/- + COLOR OF URINE Normal Yellow Dark Yellow COLOR OF STOOL Clay Colour PRURITUS -- ICTERUS Lemon Yello Greenish/Dark Yellow LIVER GALL BLADDER S BILLIRUBIN 4-5mg/dl(Indirect) Up to 10-12mg/dl(Indirect/Direct) 15-20mg/dl(Direct) SGOT/SGPT Elevated Markedly Elevated Normal/Elevated ALK PHOSPHATASE Noraml S PROTEINS Decrease

Causes of Obstructive Jaundice Most Common is Common Bile Duct Stone Periampullary Carcinoma( Ca Head Pancreas most Common) Periampullary Malignancy includes Malignancy of Head Pancreas Ampulla of Vater Malignancy Lower End CBD Malignancy & Duodenal Malignancy

Causes Hepatic Duct Cholangiocarcinoma e.g KLATSKIN TUMOR( TUMOR involving Hepatic Duct Bifurcation). Extrinsic Pressure by Portal Lymphnodes due to Metastasis or Lymphoma.

Common Bile Duct Common Bile Duct Stone. Common Bile Duct Stricture. Gall Bladder Carcinoma.(Extrinsic Compression) Choledochal Cyst Obstruction by Ascaris Lumbricoides & Clonorchis Sinensis. Mirrizi’s Syndrome Stone in Cystic Duct or Hartmann’s Pouch causing pressure obstruction of Common Bile Duct.

Pancrease Periampullary Carcinoma Carcinoma of Head of Pancreas. Pseudocyst of Pancreas.(Extrinsic Compression)

PATHOPHYSIOLOGY OF OBSTRUCTIVE JAUNDICE Obstructive jaundice is a condition in which there is blockage of the flow of bile out of the liver. This results in an overflow of bile and its by-products into the blood, and bile excretion from the body is incomplete. Hepatic functions Protein synthesis, Reticulo-endothelial function Hepatic metabolism Coagulation defect..increased prothrombin time(Decreased absroption of fat solube vitamins A,D,E,K(decreased factor XI ,XII ,platelets) Renal functions Renal vasoconstriction Activation of complement system causing peritubular and glomerular fibrin deposition leading to tubular and cortical necrosis Cardiovascular effects Decreased peripheral vascular resistance Bradycardia due to direct effect of bile salts on SA node Decreased cardiac contractability Delayed wound healing due to defective synthesis of collagen

History Age Abdominal Pain Fever Urine Stool Pruritus Anorexia & Weight Loss

Physical Examination Icterus: Usually dark yellow may have a greenish tinge if bilirubin is reduced to billiverdin. Jaundice 1. Fluctuant in case of CBD Stones & Ampullary Growth. 2. Progressive in case of malignant obstruction by Carcinoma of Head of Pancrease Hepatomegaly

Physical Examination

COURVOISIER’S LAW PALPABLE GALL BLADDER  A nontender palpable gall bladder in a patient of jaundice is normally not due to stone obstructing the bile duct whereas other causes are common by comparison.  Explanation of Courvoisier's Law:: If in a jaundice patient GB is enlarged it is not a case of stone impacted in the CBD as previous inflammation leads to Gall Bladder Fibrotic and non distensible. Causes are Carcinoma of Head of Pancreas & Periampullary Carcinoma. Exceptions of Curvoisier’s Law Double Impaction of Stone( CBD & Cystic Duct) Stone at Ampulla Of Vater Oriental Cholangiohepatitits Mirrizi’s Syndrome

Bio Chemical Test 1 S Billirubin: In Surgical Jaundice there will be(Direct) hyperbilirubinemia. Normal 0.2 -1.0mg/dl Usually in CBD Stones S Bil(Total) is <10mg/dl. Usually in Neoplastic Obstruction S Bil(Total) is >10mg/dl. Total Billirubin rise upto a plateau level of 25-30mgdl at this lever patient has loss in urine=daily Production. Liver Function Test Interpretation is (Total B/Direct B/AST/ALT/Alk Pho)

Bio Chemical Test 2 SGOT/SGPT(AST/ALT) : Normal level is 5-35IU/L Modest rise in Surgical Jaundice. AST if more than 1000IU/L s/o Medical Jaundice due to Hepatitis. ALT (SGPT) more specific for Liver Injury due to any cause.

Biochemical Test 3 Serum Alkaline Phosphatase Normal level 3-13 KA Units/L or 60-300 IU/L. S ALK Phosphatase is usually raised in obstructive jaundice but not so in hepatocellular Jaundice. If the level is more than >30 KA Units S/O Significant Obstructive Jaundice. Increased value are because of increase production so it may be elevated before the S Billirubin value raises. Serum Alk Phosphatase also increased in disease of intestine and bone.

Bio Chemical Test 4 Serum 5’ Nucleotidase. Leucine Aminopeptidase Gamma Glautamyl Transpeptidase  All of the above enzymes are more specific for Biliary Obstruction.

Bio Chemical Test 5 Serum Albumin : Noraml level is 3.0 to 5.5 gm/Dl Usually normal in Obstructive Jaundice but low value suggest parenchymal dysfunction as in hepatocellular Jaundice. It may decrease when liver is affected by metastatic Nodules.

Bio Chemical Test 6 Prothrombin Time It is usually expressed as INR Normal: Control is 15 Seconds & Normal INR is <1.5 PT is elevated because of decrease in synthesis of VIT K depedent clotting factors( which is a fat soluble vitamins which is not absorbed in obstructive jaundice)

Bio Chemical Test 7 Urine Examination : Froth’s Test to detect Conjugated Billirubin. Hay’s Test to detect presence of Bile Salt in Urine. Fouchet’s Test to detect Bile Pigment in Urine. ABSENT UROBILLINOGEN IN URINE Stool:: Clay Color Stool for Occult blood in case of Ampullary Malignancy

Radiological Investigation: USG Findings will be Presence of Dilated IHBR is s/o of Obstructive Jaundice. CBD Diameter (Normal is 7-8 mm) if it is more than 8 mm suggestive of dilatation. Gall Stone and CBD Stone Can be identified. Mass in CBD can be detected if it is >2 cm. Pancreatic Head Malignancy detected if >2 cm. Presence of Liver Metastasis and Ascites.

USG Images

Radiological Investigation CECT Abdomen Higher Sensitivity and Specificity than USG for detection of bile duct/pancreatic masses of 1-2 cm diameter. It is useful in determining resectability of cancer of Bile Duct or Pancreatic Head Masses. It visualise the course of Bile Duct better than USG and hence more likely demonstrated the level & Cause of Ductal Obstruction. Although USG better (more Sensitive )than CT Scan for detecting GB Stone CECT is better(More Sensitive) for documenting CBD Stone.

CECT Abdomen

CECT Best for Pancreatic Carcinoma(Highly sensitive for lesion >1mm).

Gallbladder Dilated bile ducts Mass in head of the pancreas

Radiological Investigation: Barium Meal: Reverse 3 Sign of Frostberg. Hypotonic Duodenography::Rose Thorn appearance

Clinical Classification of Obstructive Jaundice Type I Complete Obstruction(Classical Symptoms with Biochemical Changes) Malignancy of Head of Pancreas. Ligation of Common Bile Duct. Cholangiocarcinoma. Parenchymal Liver Disease. Type II Intermittent Obstruction(Symptoms with Biochemical Changes But Jaundice may or may not be Present). 1. Choledocholithiasis Periampullary tumor Duodenal diverticula Choledochal Cyst Papillomas of the bile duct Intra biliary parasites Hemobilia

Clinical Classification Type III Chronic Intermittent Obstruction(With or without classical symptoms but pathological changes are present in bile duct and liver ) 1. Strictures of the CBD Congenital Traumatic Sclerosing cholangitis Post radiotherapy Stenosed biliary enteric anastomosis Cystic fibrosis Chronic pancreatitis Stenosis of the Sphincter of Oddi Type IV Segmental Obstruction( One or more segment of IHB Radical) Traumatic Slerosing Cholangitis IntraHepatic Abscess Cholangiocarcinoma

Endoscopic Retrograde Cholangiopancreatography(ERCP) It is combined Endoscopic & Radiological Approach. IND:: When USG s/o dilated IHBR with dilated CBD i.e Obstruction is suspected to be at the lower biliary tract or near pancreatic head.

ERCP

ERCP Normal ERCP Normal ERCP

Biliary stricture due to cholangiocarcinoma Bile duct obstruction from chronic pancreatitis

ERCP Advantages:: Endoscopic Visualization of duodenum to rule out duodenal obstruction. Endoscopic Sphincterotomy with dormia basket removal of CBD Stone. Biopsy & Cytology. Endoscopic Biliary Stent placement for non surgical palliation. It is contraindicated in Recurrant Acute Pancreatitis & Unfavourable anatomy. Complication Pancreatitis Cholangitis Hemorrhage Sepsis

Radiological Investigation ENDO USG It is more accurate than combined ERCP & CT Scan in defining the nature & extent of the cause of Biliary Obstruction. It is also quite sensitive in determining the resectability in periampullary malignancy. EUS 98% Sensitivr in diagnosis of etiology of Obstructive Jaundice. It allows us to take tissue sampling by EUS guided FNAC.

EUS The sensitivity of EUS for the identification of focal mass lesions in pancreas has been reported to be superior to that of CT scanning, both traditional and spiral, particularly for tumors smaller than 3 cm in diameter. Compared to MRCP for the diagnosis of biliary stricture, EUS has been reported to be more specific (100% vs 76%).

Technique of PTC & corresponding Cholangiogram

Percutaneous Transhepatic Cholangiography For Visualization of Biliary Tract by instillation of contrast material directly into a bile duct. IND: PTC indicated when USG shows dilated IHBR but the CBD is not dilated i.e Obstruction is suspected in the upper Biliary Tract. CI: Coagulopathy & Ascites Complication: Bleeding Bile Leak Hemobilia Cholangitis

PTC & ERCP PTC & ERCP are not contradictory to each other they are supplementary investigation to each other.

MRCP(Magnetic Resonance CholangioPancreatography) MRCP is based on principle of visualization of ducts containing bile on T2 Weighted Images. Advnatages: Non Invasive No Contrast media is required. Will show both upper & Lower level of obstruction . Excellent ductal anatomy is visualized .

MRCP Distal CBD Stone PSC

Algorithm for Diagnostic approach to a patient of Surgical Jaundice. Physical Examination& LFT Surgical Jaundice USG Abdomen 1.CBD Stone 2. Periampullary Malignancy 3. Liver Metastasis or Peritoneal metastasis Dilated IHBR (True Surgical Jaundice)

Treatment Surgical /Palliation Continued Common Bile Duct Not Dilated PTC+CECT Treatment Surgical /Palliation Dilated>8.0MM ERCP+CECT Treatment Surgical/Palliation

Prognostic factors ( Pitt’s score) Parameters Type of obstruction(malignant or benign) Age > 60 yrs S.Alb< 3gm/dl S.Bil > 10mg% S.Alk P > 100 IU S.Creatinine >1.3mg% TLC >10000/mm3 Hematocrit < 30% Factors Mortality Upto 2 0% 3 4% 4 7% 5 44% 6 67% 8 100%

Treatment of CBD Stone **Stone is the CBD & Gall Bladder Open Cholecystectomy with CBDExploaration(Choledochotomy ) followed by T Tube Drainage. ERCP with Sphincterotomy with Removal of Stone followed by Lap Cholecystectomy. ** Stones in the CBD but Gall Bladder is Absent (Post Cholecystectomy) or Treatment of Retained Stone: ERCP with Sphincterotomy with Removal of Stone. BURHENNE Technique: Removal of Stone by dilating the T tube Tract through Cystic Duct. Choledochoscopic Removal of Stone.

Periampullary Carcinoma of Carcinoma of Head of Pancreas Resectable Tumors Curative Surgery is to be done in those cases where no distant metastasis (Liver of Celiac Nodes) & No Vascular(SMA & Portal Vein Invasion) Surgery : WHIPPLE’S Pancreaticoduodenectomy Resection of Distal Stomach Gall Bladder Whole Common Bile Duct with Head of Pancreas & 10-15 cm of Jejunum with Regional Nodes. Reconstruction done with following anastomosis PancreaticoJejunostomy /PancreatoGastrostomy Hepaticojejunostomy Gastrojejunostomy

Pylorus Preserving Panceatoduodenoctomy In this Procedure Pylorus is Preserved to maintain the physiology of GIT. ADVANTAGES: DISADVANTAGES:

Whipple’s PD Whipple’s Operation has high morbidity & Mortality rates. 40% if done by inexperienced surgeon. 5% done by experienced surgeon. Complication Hemorrhage Pancreatic Fistula Biliary Fistula

Non Resectable Tumors: Palliation to Decrease Symptoms Non Surgical Palliation Biliary Drainage via Percuataneous Stent ERCP with Metal Stent Preferred for patients in poor general condition & patient those not fit for surgery. For GOO: Either Stent Placement or Gastrojejunostomy is required. Surgical Palliation Single Bypass: Cholecystojejunostomy Double Bypass Choledochojejunostomy & Jejunojejunostomy Triple Bypass Choledochojejunostomy with Gastrojejunostomy with jejunojejunostomy.

Bile Duct Cancer Resectable Proximal Duct Cancer Resect the involved segment with with Roux EnY Hepaticojejunostomy. 2. Distal Bile Duct Cancer Whipples Procedure Unresectable 1.Non Surgical Palliation by Biliary Drainage Procedure via PTBD or ERCP. 2.Surgical Palliation by Roux En Y Hepaticojejunostomy.

Complication of Obstructive Jaundice Renal Failure Bleeding Sepsis

Thank You !